Atlas Trials

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

Clinical trial NCT04655612 · COMPLETED

Trial details

NCT number
NCT04655612
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19SARS-CoV InfectionRheumatoid ArthritisSpondyloarthritisAnkylosing SpondylitisPsoriatic Arthritis
Start date
2020-12-01
Primary completion
2021-07-01
Enrollment
5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.